Cetacaine Anesthetic Solution
NDC Package 10223-0202-2
Package Information
Cetacaine Anesthetic (benzocaine, butamben, and tetracaine hydrochloride) solution is cetacaine is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. This formulation utilizes a solution delivery system. Marketed by Cetylite Industries, Inc., this product is identified by NDC 10223-0202.
Identification & Billing
- RxCUI: 543786 - benzocaine 14 % / butamben 2 % / tetracaine HCl 2 % Mucous Membrane Topical Solution
- RxCUI: 543786 - benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucous Membrane Topical Solution
- RxCUI: 543789 - Cetacaine LIQUID 14 % / 2 % / 2 % Mucous Membrane Topical Solution
- RxCUI: 543789 - benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucous Membrane Topical Solution [Cetacaine]
- RxCUI: 543789 - Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Mucous Membrane Topical Solution
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Ester Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Esters - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Local Anesthesia - [PE] (Physiologic Effect)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 10223 - Cetylite Industries, Inc.
- 10223-0202 - Cetacaine Anesthetic
- 10223-0202-2 - 1 BOTTLE, GLASS in 1 BOX / 14 g in 1 BOTTLE, GLASS
- 10223-0202 - Cetacaine Anesthetic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (10223-0202). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10223-0202-2 identifies a specific commercial package of 1 bottle, glass in 1 box / 14 g in 1 bottle, glass of Cetacaine Anesthetic, a human prescription drug labeled by Cetylite Industries, Inc.. This product is billed per "GM" gram and contains an estimated amount of 14 billable units per package. This solution is formulated for topical use and contains benzocaine; butamben; tetracaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cetylite Industries, Inc. on January 01, 1960. The current certification is valid through December 31, 2026.
How is this Cetylite Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10223020202. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 14 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.